688621 阳光诺和
已收盘 12-23 15:00:00
资讯
新帖
简况
阳光诺和收盘上涨0.05%，滚动市盈率19.24倍
金融界 · 12-23 20:35
阳光诺和收盘上涨0.05%，滚动市盈率19.24倍
阳光诺和：12月19日召开分析师会议，广发证券、光大保德信基金等多家机构参与
证券之星 · 12-23 17:21
阳光诺和：12月19日召开分析师会议，广发证券、光大保德信基金等多家机构参与
阳光诺和：截至目前新拓客户和订单趋势良好
格隆汇 · 12-23 15:45
阳光诺和：截至目前新拓客户和订单趋势良好
阳光诺和：12月17日接受机构调研，国联证券、华夏久盈参与
证券之星 · 12-20
阳光诺和：12月17日接受机构调研，国联证券、华夏久盈参与
阳光诺和12月20日获主力加仓239万元 环比增加1607.14%
市场透视 · 12-20
阳光诺和12月20日获主力加仓239万元 环比增加1607.14%
阳光诺和12月16日遭主力抛售388万元 环比增加762.22%
市场透视 · 12-16
阳光诺和12月16日遭主力抛售388万元 环比增加762.22%
阳光诺和变更会计师事务所，聘政旦志远审计2024年财报
财中社 · 12-13
阳光诺和变更会计师事务所，聘政旦志远审计2024年财报
阳光诺和12月09日获主力加仓846万元 环比增加320.90%
市场透视 · 12-09
阳光诺和12月09日获主力加仓846万元 环比增加320.90%
阳光诺和股价涨5% 医疗开放政策
智选洞察 · 12-09
阳光诺和股价涨5% 医疗开放政策
阳光诺和12月03日遭主力抛售1511万元 环比增加202.20%
市场透视 · 12-03
阳光诺和12月03日遭主力抛售1511万元 环比增加202.20%
阳光诺和11月27日遭主力抛售1201万元 环比增加664.97%
市场透视 · 11-27
阳光诺和11月27日遭主力抛售1201万元 环比增加664.97%
阳光诺和（688621）11月26日主力资金净卖出331.99万元
证券之星 · 11-27
阳光诺和（688621）11月26日主力资金净卖出331.99万元
【机构调研记录】长盛基金调研海大集团、阳光诺和等6只个股（附名单）
证券之星 · 11-26
【机构调研记录】长盛基金调研海大集团、阳光诺和等6只个股（附名单）
阳光诺和：11月22日接受机构调研，海通证券、超弦基金等多家机构参与
证券之星 · 11-25
阳光诺和：11月22日接受机构调研，海通证券、超弦基金等多家机构参与
阳光诺和：公司现在的新签订单中临床业务的占比已经接近50%
每日经济新闻 · 11-20
阳光诺和：公司现在的新签订单中临床业务的占比已经接近50%
阳光诺和：本公司暂未涉足CDMO委托生产服务领域
每日经济新闻 · 11-20
阳光诺和：本公司暂未涉足CDMO委托生产服务领域
阳光诺和：11月15日接受机构调研，中金证券、国投瑞银等多家机构参与
证券之星 · 11-19
阳光诺和：11月15日接受机构调研，中金证券、国投瑞银等多家机构参与
阳光诺和：本公司自主研发并储备的产品，多于临床批件获取前后实现转让，并同时锁定后续服务
证星董秘互动 · 11-19
阳光诺和：本公司自主研发并储备的产品，多于临床批件获取前后实现转让，并同时锁定后续服务
阳光诺和2024Q3财报点评：Q3营收高增 自研品种不断推进
长江证券 · 11-17
阳光诺和2024Q3财报点评：Q3营收高增 自研品种不断推进
11月15日阳光诺和跌5.14%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 11-15
11月15日阳光诺和跌5.14%，融通健康产业灵活配置混合A/B基金重仓该股
加载更多
公司概况
公司名称：
北京阳光诺和药物研究股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-06-21
主营业务：
北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务，致力于协助中国医药制造企业加速实现进口替代和自主创新。公司的主要包括药物发现、药理药效、药学研究、临床研究和生物分析。报告期内公司参与研发和自主立项研发的项目中，共8项新药项目已通过NMPA批准进入临床试验，70项药品申报上市注册受理，8项一致性评价注册受理；取得39项药品生产注册批件；7项通过一致性评价，6项原料药通过审评获批。
发行价格：
26.89
{"stockData":{"symbol":"688621","market":"SH","secType":"STK","nameCN":"阳光诺和","latestPrice":38.02,"timestamp":1734937200000,"preClose":38,"halted":0,"volume":2597796,"delay":0,"floatShares":112000000,"shares":112000000,"eps":1.9766,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"12-23 15:00:00","open":38.04,"high":38.86,"low":37.82,"amount":99617200,"amplitude":0.0274,"askPrice":38.02,"askSize":1,"bidPrice":38.01,"bidSize":164,"shortable":0,"etf":0,"ttmEps":1.9766,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"adjPreClose":38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":41.8,"lowLimit":34.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":112000000,"pbRate":3.77,"roa":"--","roe":"19.74%","epsLYR":1.65,"committee":0.783383,"marketValue":4258000000,"floatMarketCap":4258000000,"peRate":19.23505,"changeRate":0.0005,"turnoverRate":0.0232,"status":0,"afterMarket":{"amount":0,"volume":0,"close":38.02,"buyVolume":0,"sellVolume":0,"time":1734939238975,"indexStatus":"已收盘 12-23 15:30:00","preClose":38}},"requestUrl":"/m/hq/s/688621","defaultTab":"news","newsList":[{"id":"2493549377","title":"阳光诺和收盘上涨0.05%，滚动市盈率19.24倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2493549377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493549377?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:35","pubTimestamp":1734957338,"startTime":"0","endTime":"0","summary":"12月23日，阳光诺和今日收盘38.02元，上涨0.05%，滚动市盈率PE达到19.24倍。从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均43.62倍，行业中值42.93倍，阳光诺和排名第14位。股东方面，截至2024年9月30日，阳光诺和股东户数7495户，较上次增加2408户，户均持股市值35.28万元，户均持股数量2.76万股。北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务，致力于协助中国医药制造企业加速实现进口替代和自主创新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223203936ab8e0852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223203936ab8e0852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2493945739","title":"阳光诺和：12月19日召开分析师会议，广发证券、光大保德信基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2493945739","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493945739?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:21","pubTimestamp":1734945684,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月23日阳光诺和发布公告称公司于2024年12月19日召开分析师会议，广发证券、光大保德信基金、盘京资产、明德资本、华安证券、富荣基金、华泰证券、弥远投资参与。截至目前新拓客户和订单趋势良好。阳光诺和2024年三季报显示，公司主营收入9.17亿元，同比上升32.47%；归母净利润2.08亿元，同比上升21.4%；扣非净利润2.02亿元，同比上升20.19%；其中2024年第三季度，公司单季度主营收入3.54亿","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300023857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0276","688621","BK0216","SG9999001093.SGD","BK0012","BK0183","01776","BK1564","BK1147","000776"],"gpt_icon":0},{"id":"2493787866","title":"阳光诺和：截至目前新拓客户和订单趋势良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2493787866","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493787866?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:45","pubTimestamp":1734939906,"startTime":"0","endTime":"0","summary":"格隆汇12月23日丨阳光诺和(688621.SH)披露投资者关系活动记录表显示，企业所具备的“临床前+临床”一体化研发服务模式展现出显著的竞争优势，该模式能够充分满足客户多元化的服务需求，进而提升药物研发的成功率与效率。这种优势有助于增强企业获取订单的能力。面对当前行业内竞争的加剧，企业采取了更为积极的市场拓展策略，通过定期与客户进行项目规划的沟通，以确保研发服务的精准对接。截至目前新拓客户和订单趋势良好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223154540ab8d5523&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223154540ab8d5523&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2492415780","title":"阳光诺和：12月17日接受机构调研，国联证券、华夏久盈参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492415780?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:03","pubTimestamp":1734692620,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月20日阳光诺和发布公告称公司于2024年12月17日接受机构调研，国联证券、华夏久盈参与。2024年8月，公司与北京万泰利克药业有限公司签署了战略合作协议，双方优势互补、资源共享，将共同推进中药研发事业创新发展。该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000035437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01456","688621","601456","BK0276","BK1147","BK1564","BK0216"],"gpt_icon":0},{"id":"2492938124","title":"阳光诺和12月20日获主力加仓239万元 环比增加1607.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492938124","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492938124?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:21","pubTimestamp":1734679282,"startTime":"0","endTime":"0","summary":"12月20日, 阳光诺和股价涨1.33%，报收38.00元，成交金额8793万元，换手率2.06%，振幅2.21%，量比1.03。阳光诺和今日主力资金净流入239万元，连续3日净流入，上一交易日主力净流入14万元，今日环比增加1607.14%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为44.44%，平均涨幅为1.99%。该股近5个交易日下跌6.82%，主力资金累计净流入593万元；近20日主力资金累计净流出3114万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220160526a1fd2172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220160526a1fd2172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2492614588","title":"阳光诺和12月16日遭主力抛售388万元 环比增加762.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492614588","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492614588?lang=zh_cn&edition=full","pubTime":"2024-12-16 15:20","pubTimestamp":1734333641,"startTime":"0","endTime":"0","summary":"12月16日, 阳光诺和股价跌3.04%，报收39.54元，成交金额8142万元，换手率1.82%，振幅3.24%，量比0.70。阳光诺和今日主力资金净流出388万元，上一交易日主力净流出45万元，今日环比增加762.22%。|12月16日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|红四方|9.84%|#|天玑科技|7.83%|#|宏达新材|7.73%|#|乐心医疗|7.13%|#|创新医疗|6.20%|#|博创科技|5.89%|#|科德教育|5.58%|#|天元智能|5.05%|#|瀛通通讯|4.77%|#|中公教育|4.44%|阳光诺和所在的医疗服务行业，今日主力净流出1.78亿元，行业排名39/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216154109ab7bb420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216154109ab7bb420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2491301507","title":"阳光诺和变更会计师事务所，聘政旦志远审计2024年财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301507","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301507?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:34","pubTimestamp":1734082454,"startTime":"0","endTime":"0","summary":"政旦志远在最近一个会计年度的审计业务收入为259万元，并为16家上市公司出具了2023年度财务报表审计报告，显示出其在行业内的经验和能力。大华对本次变更事项无异议，且公司与前后任会计师事务所均已充分沟通。2024年前三季度，阳光诺和实现收入9.17亿元，归母净利润2.08亿元。文章来源：财中社阳光诺和变更会计师事务所，聘政旦志远审计2024年财报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213180929ab750054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213180929ab750054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621"],"gpt_icon":0},{"id":"2490271292","title":"阳光诺和12月09日获主力加仓846万元 环比增加320.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490271292","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490271292?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:20","pubTimestamp":1733728820,"startTime":"0","endTime":"0","summary":"12月09日, 阳光诺和股价跌0.63%，报收42.69元，成交金额1.78亿元，换手率3.64%，振幅6.87%，量比2.71。阳光诺和今日主力资金净流入846万元，上一交易日主力净流入201万元，今日环比增加320.90%。|12月09日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|申昊科技|6.49%|#|一彬科技|5.87%|#|智能自控|5.30%|#|星德胜|5.21%|#|新瀚新材|5.15%|#|三丰智能|5.04%|#|铭科精技|4.63%|#|惠发食品|4.32%|#|蓝黛科技|4.11%|#|喜悦智行|3.87%|阳光诺和所在的医疗服务行业，今日主力净流入2.50亿元，行业排名12/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209153616a1dfc3a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209153616a1dfc3a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2490767971","title":"阳光诺和股价涨5% 医疗开放政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767971","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767971?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707824,"startTime":"0","endTime":"0","summary":"12月09日，阳光诺和股价大幅上涨，截至09点30分，阳光诺和上涨5.40%，报45.28元/股，成交1106万元，换手率0.22%，振幅1.09%。资金动向截止发稿，阳光诺和获得主力净流入223万元，其中超大单流入225万元，大单流出2万元。最新财报显示，今年三季报，阳光诺和实现营业收入9.17亿元，同比增长32.47%，净利润为2.08亿元，同比增长21.40%，基本每股收益为1.85元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093136a1df029f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093136a1df029f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621","159891"],"gpt_icon":0},{"id":"2488946961","title":"阳光诺和12月03日遭主力抛售1511万元 环比增加202.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946961","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488946961?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:20","pubTimestamp":1733210405,"startTime":"0","endTime":"0","summary":"12月03日, 阳光诺和股价跌1.12%，报收42.25元，成交金额6332万元，换手率1.34%，振幅2.22%，量比0.86。阳光诺和今日主力资金净流出1511万元，连续3日净流出，上一交易日主力净流出500万元，今日环比增加202.20%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为62.50%，平均跌幅为2.55%。该股近5个交易日上涨0.69%，主力资金累计净流出2898万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出8122万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153330abf20bb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153330abf20bb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2486192908","title":"阳光诺和11月27日遭主力抛售1201万元 环比增加664.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486192908","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486192908?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:21","pubTimestamp":1732692104,"startTime":"0","endTime":"0","summary":"11月27日, 阳光诺和股价涨0.36%，报收42.11元，成交金额7962万元，换手率1.71%，振幅2.98%，量比0.97。阳光诺和今日主力资金净流出1201万元，连续5日净流出，上一交易日主力净流出157万元，今日环比增加664.97%。净流出前三个股分别为美年健康、阳光诺和、药明康德。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153929abe29d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153929abe29d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2486852526","title":"阳光诺和（688621）11月26日主力资金净卖出331.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486852526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486852526?lang=zh_cn&edition=full","pubTime":"2024-11-27 08:13","pubTimestamp":1732666420,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月26日收盘，阳光诺和报收于41.96元，上涨2.84%，换手率1.78%，成交量2.0万手，成交额8328.87万元。近5日资金流向一览见下表：阳光诺和融资融券信息显示，融资方面，当日融资买入564.45万元，融资偿还966.94万元，融资净偿还402.48万元。阳光诺和主营业务：创新药开发,仿制药开发及一致性评价等方面的综合研发服务,服务内容主要包括药物发现,药学研究,临床试验和生物分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700007355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2486497098","title":"【机构调研记录】长盛基金调研海大集团、阳光诺和等6只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486497098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486497098?lang=zh_cn&edition=full","pubTime":"2024-11-26 08:02","pubTimestamp":1732579375,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月25日披露的机构调研信息，长盛基金近期对6家上市公司进行了调研，相关名单如下：1）海大集团 个股亮点：采取“自繁自养”和“公司+农户”两种模式,打造“猪苗饲料动保-养猪-肉制品”产业链2）阳光诺和 个股亮点：公司主营业务是为医药企业提供专业化研发外包服务；公司目前利用固相合成技术已经可以稳定合成司美格鲁肽、替尔泊肽等药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600007557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0238","BK0188","BK0070","BK0196","002311","688621","BK0187","BK0216"],"gpt_icon":0},{"id":"2486222701","title":"阳光诺和：11月22日接受机构调研，海通证券、超弦基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2486222701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486222701?lang=zh_cn&edition=full","pubTime":"2024-11-25 18:33","pubTimestamp":1732530797,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月25日阳光诺和发布公告称公司于2024年11月22日接受机构调研，海通证券、超弦基金、长盛基金、融通、民生加银、浦银安盛、摩根基金参与。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500025332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1147","BK0012","BK0183","BK0216","BK0070","BK1564","688621","600837","BK0028","BK0276","06837"],"gpt_icon":0},{"id":"2484183459","title":"阳光诺和：公司现在的新签订单中临床业务的占比已经接近50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484183459","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484183459?lang=zh_cn&edition=full","pubTime":"2024-11-20 07:53","pubTimestamp":1732060402,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：目前公司创新药订单的占比是多少？阳光诺和（688621.SH）11月19日在投资者互动平台表示，公司临床业务经过多年临床项目经验的积累，在创新药大临床上形成了自己的优势适应症领域，目前在上海、北京、成都、南京等地均有布局，公司现在的新签订单中临床业务的占比已经接近50%。此外，在药学业务范畴内，我们还涉及部分改良型新药的研究工作。本公司创新药订单呈现出稳健增长的态势，自研立项并储备的1类创新药项目共计12项。同时，公司进一步强化了创新药临床业务的商务拓展力度，确保充足的在手订单，为公司的收入快速增长奠定了坚实基础。(记者 张喜威)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120075423a246e9ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120075423a246e9ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2484834561","title":"阳光诺和：本公司暂未涉足CDMO委托生产服务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2484834561","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484834561?lang=zh_cn&edition=full","pubTime":"2024-11-20 07:53","pubTimestamp":1732060398,"startTime":"0","endTime":"0","summary":"因阳光诺和也涉及持有品种再转让，以及下游客户受让药品之后的再委托生产。对此《征求意见稿》出台背景、具体第十七条、第十条涉及的影响有哪些？预计《征求意见稿》通过率怎么样？目前，本公司暂未涉足CDMO委托生产服务领域，故该制度对本公司的运营不构成重大影响。此外，该类征求意见稿在正式颁布之前，将历经一个公开征求公众意见的阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120075421abd06177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120075421abd06177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2484914783","title":"阳光诺和：11月15日接受机构调研，中金证券、国投瑞银等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2484914783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484914783?lang=zh_cn&edition=full","pubTime":"2024-11-19 19:05","pubTimestamp":1732014301,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月19日阳光诺和发布公告称公司于2024年11月15日接受机构调研，中金证券、国投瑞银、华杰高景、海绵投资参与。公司2024年前三季度业绩稳定增长，实现营业收入9.17亿元，同比增长32.47%。实现归属于上市公司股东的净利润为5911.73万元，同比增长11.37%。公司前三季度研发费用1.20亿元，同比增长43.76%，第三季度研发费用5041.19万元，较上年同期增长69.38%，第三季度研发投入总额占营业收入的比例为14.25%，增加1.36个百分点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900031285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688621","BK0216"],"gpt_icon":0},{"id":"2484911420","title":"阳光诺和：本公司自主研发并储备的产品，多于临床批件获取前后实现转让，并同时锁定后续服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2484911420","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484911420?lang=zh_cn&edition=full","pubTime":"2024-11-19 19:00","pubTimestamp":1732014041,"startTime":"0","endTime":"0","summary":"本公司创新药订单呈现出稳健增长的态势，自研立项并储备的1类创新药项目共计12项。因阳光诺和也涉及持有品种再转让，以及下游客户受让药品之后的再委托生产。本公司自主研发并储备的产品，多于临床批件获取前后实现转让，并同时锁定后续服务。此外，该类征求意见稿在正式颁布之前，将历经一个公开征求公众意见的阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119190129a24584fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119190129a24584fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2484179506","title":"阳光诺和2024Q3财报点评：Q3营收高增 自研品种不断推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2484179506","media":"长江证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484179506?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:00","pubTimestamp":1731772800,"startTime":"0","endTime":"0","summary":"事件描述公司发布了2024 年三季度报告，2024 年前三季度实现营业收入9.17 亿元，同比增长32.47%；实现归母净利润2.08 亿元，同比增长21.40%；实现扣非归母净利润2.02 亿元，同比增长20.19%。事件评论Q3 营收高增长，现金流改善显著。营收的高增长得益于公司进一步加强市场商务拓展，业务订单充足。2024 年第三季度公司研发费用为5041 万元，研发费用率达14.25%，公司坚持研发投入，研发费用率长期维持在较高水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111714061995be3eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111714061995be3eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621"],"gpt_icon":0},{"id":"2483348066","title":"11月15日阳光诺和跌5.14%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348066?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:12","pubTimestamp":1731658325,"startTime":"0","endTime":"0","summary":"证券之星消息，11月15日阳光诺和跌5.14%，收盘报42.6元，换手率2.18%，成交量2.44万手，成交额1.07亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500025154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688621"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-21","address":"北京市昌平区科技园区双营西路79号院7号楼一层","stockEarnings":[{"period":"1week","weight":-0.0384},{"period":"1month","weight":-0.0658},{"period":"3month","weight":0.2225},{"period":"6month","weight":-0.1555},{"period":"1year","weight":-0.4027},{"period":"ytd","weight":-0.4527}],"companyName":"北京阳光诺和药物研究股份有限公司","boardCode":"AI0073","perCapita":"14943股","boardName":"研究和试验发展","registeredCapital":"11200万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务，致力于协助中国医药制造企业加速实现进口替代和自主创新。公司的主要包括药物发现、药理药效、药学研究、临床研究和生物分析。报告期内公司参与研发和自主立项研发的项目中，共8项新药项目已通过NMPA批准进入临床试验，70项药品申报上市注册受理，8项一致性评价注册受理；取得39项药品生产注册批件；7项通过一致性评价，6项原料药通过审评获批。","serverTime":1734975344802,"listedPrice":26.89,"stockholders":"7495人(较上一季度增加47.34%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阳光诺和,688621,阳光诺和股票,阳光诺和股票老虎,阳光诺和股票老虎国际,阳光诺和行情,阳光诺和股票行情,阳光诺和股价,阳光诺和股市,阳光诺和股票价格,阳光诺和股票交易,阳光诺和股票购买,阳光诺和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}